Literature DB >> 9163431

Atomic structure of the ectodomain from HIV-1 gp41.

W Weissenhorn1, A Dessen, S C Harrison, J J Skehel, D C Wiley.   

Abstract

Fusion of viral and cellular membranes by the envelope glycoprotein gp120/gp41 effects entry of HIV-1 into the cell. The precursor, gp160, is cleaved post-translationally into gp120 and gp41 which remain non-covalently associated. Binding to both CD4 and a co-receptor leads to the conformational changes in gp120/gp41 needed for membrane fusion. We used X-ray crystallography to determine the structure of the protease-resistant part of a gp41 ectodomain solubilized with a trimeric GCN4 coiled coil in place of the amino-terminal fusion peptide. The core of the molecule is found to be an extended, triple-stranded alpha-helical coiled coil with the amino terminus at its tip. A carboxy-terminal alpha-helix packs in the reverse direction against the outside of the coiled coil, placing the amino and carboxy termini near each other at one end of the long rod. These features, and the existence of a similar reversal of chain direction in the fusion pH-induced conformation of influenza virus HA2 and in the transmembrane subunit of Moloney murine leukaemia virus (Fig. 1a-d), suggest a common mechanism for initiating fusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163431     DOI: 10.1038/387426a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  744 in total

1.  Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.

Authors:  I Muñoz-Barroso; K Salzwedel; E Hunter; R Blumenthal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.

Authors:  D Schenten; L Marcon; G B Karlsson; C Parolin; T Kodama; N Gerard; J Sodroski
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E.

Authors:  S L Allison; K Stiasny; K Stadler; C W Mandl; F X Heinz
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus.

Authors:  M I Vázquez; M Esteban
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  The role of position a in determining the stability and oligomerization state of alpha-helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteins.

Authors:  K Wagschal; B Tripet; P Lavigne; C Mant; R S Hodges
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

6.  Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers.

Authors:  X Yang; R Wyatt; J Sodroski
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.

Authors:  J Chen; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.

Authors:  H Qiao; R T Armstrong; G B Melikyan; F S Cohen; J M White
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

9.  A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses.

Authors:  M Shmulevitz; R Duncan
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

10.  Structure-function studies of the self-assembly domain of the human immunodeficiency virus type 1 transmembrane protein gp41.

Authors:  Y Weng; Z Yang; C D Weiss
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.